Status:
UNKNOWN
Initial Manifestations of Congestive Heart Failure in Patients With NSTEACS
Lead Sponsor:
National Medical Research Center for Therapy and Preventive Medicine
Collaborating Sponsors:
Moscow City Hospital named after A.K. Eramishantsev
Conditions:
Acute Heart Failure, Non-ST-segment Elevation Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Acute heart failure (HF) is a common complication of acute coronary syndrome (ACS) associated with poor prognosis. Diagnosis of congestive HF in patients with initial, non-severe symptoms and signs ma...
Eligibility Criteria
Inclusion
- Patients hospitalized to the cardiac intensive care unit with ACS without persistent ST-segment elevation
- Signed informed consent
Exclusion
- ACS with persistent ST-segment elevation
- High probability of absence of ACS
- Congestive rales in the base of lungs, cardiac asthma, pulmonary edema, cardiogenic shock, obvious edema, anasarca
- History of severe chronic heart failure (III-IV NYHA class, obvious edema, anasarca)
- Continuous use of loop diuretics
Key Trial Info
Start Date :
January 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 28 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04739098
Start Date
January 30 2020
End Date
August 28 2024
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation and City clinical hospital named after A. K. Eramishantsev, Moscow, Russia, 129327
Moscow, Russia, 101990